Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cerebral Angiography | 39 | 2024 | 1262 | 6.820 |
Why?
|
Cerebral Hemorrhage | 40 | 2023 | 2648 | 4.510 |
Why?
|
Carotid Stenosis | 13 | 2024 | 861 | 1.840 |
Why?
|
Hematoma | 16 | 2020 | 766 | 1.810 |
Why?
|
Tomography, X-Ray Computed | 52 | 2025 | 20660 | 1.800 |
Why?
|
Cerebrovascular Disorders | 7 | 2024 | 1470 | 1.720 |
Why?
|
Magnetic Resonance Angiography | 12 | 2024 | 1426 | 1.670 |
Why?
|
Aneurysm, Ruptured | 4 | 2020 | 456 | 1.330 |
Why?
|
Intracranial Hemorrhages | 7 | 2023 | 814 | 1.230 |
Why?
|
Stroke | 26 | 2024 | 9747 | 1.040 |
Why?
|
Carotid Arteries | 6 | 2017 | 929 | 1.030 |
Why?
|
Intracranial Aneurysm | 5 | 2020 | 1272 | 1.030 |
Why?
|
Carotid Artery, Internal | 8 | 2022 | 437 | 0.960 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 3 | 2016 | 101 | 0.890 |
Why?
|
Tomography, Spiral Computed | 5 | 2014 | 273 | 0.880 |
Why?
|
Microscopic Polyangiitis | 1 | 2023 | 46 | 0.850 |
Why?
|
Churg-Strauss Syndrome | 1 | 2023 | 74 | 0.830 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2025 | 564 | 0.820 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2024 | 127 | 0.790 |
Why?
|
Vasospasm, Intracranial | 2 | 2024 | 206 | 0.780 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2025 | 456 | 0.750 |
Why?
|
Angiography, Digital Subtraction | 3 | 2019 | 332 | 0.720 |
Why?
|
Infarction, Middle Cerebral Artery | 3 | 2020 | 485 | 0.720 |
Why?
|
Vasculitis, Central Nervous System | 1 | 2019 | 45 | 0.650 |
Why?
|
Hospital Mortality | 9 | 2016 | 5343 | 0.620 |
Why?
|
Intracranial Thrombosis | 1 | 2020 | 109 | 0.620 |
Why?
|
Seaweed | 1 | 2018 | 18 | 0.610 |
Why?
|
Biota | 1 | 2018 | 23 | 0.600 |
Why?
|
Subarachnoid Hemorrhage | 3 | 2024 | 1022 | 0.600 |
Why?
|
Herpes Zoster Ophthalmicus | 1 | 2018 | 37 | 0.590 |
Why?
|
Sensitivity and Specificity | 23 | 2025 | 14652 | 0.590 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2019 | 137 | 0.580 |
Why?
|
Contrast Media | 12 | 2020 | 5329 | 0.570 |
Why?
|
Thrombectomy | 1 | 2022 | 681 | 0.550 |
Why?
|
Headache | 2 | 2024 | 1259 | 0.530 |
Why?
|
Ultrasonography, Doppler, Duplex | 4 | 2013 | 208 | 0.520 |
Why?
|
Ultrasonography, Doppler, Transcranial | 3 | 2016 | 276 | 0.510 |
Why?
|
Fishes | 1 | 2018 | 606 | 0.470 |
Why?
|
Thrombotic Microangiopathies | 1 | 2016 | 125 | 0.470 |
Why?
|
Aged, 80 and over | 42 | 2024 | 59488 | 0.470 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 5 | 2020 | 1224 | 0.460 |
Why?
|
Angiography | 4 | 2022 | 1581 | 0.460 |
Why?
|
Neck Injuries | 2 | 2010 | 162 | 0.450 |
Why?
|
Vasa Vasorum | 1 | 2013 | 25 | 0.440 |
Why?
|
Echoencephalography | 1 | 2014 | 133 | 0.430 |
Why?
|
Hematoma, Subdural, Intracranial | 2 | 2014 | 30 | 0.430 |
Why?
|
Carotid Artery Diseases | 4 | 2017 | 874 | 0.430 |
Why?
|
Magnetic Resonance Imaging | 23 | 2024 | 36532 | 0.430 |
Why?
|
Aged | 65 | 2024 | 171114 | 0.430 |
Why?
|
Cranial Fossa, Posterior | 1 | 2014 | 134 | 0.420 |
Why?
|
Diagnostic Imaging | 5 | 2023 | 3529 | 0.420 |
Why?
|
Middle Aged | 66 | 2024 | 223004 | 0.410 |
Why?
|
Ischemic Attack, Transient | 4 | 2024 | 870 | 0.400 |
Why?
|
Antihypertensive Agents | 5 | 2021 | 2033 | 0.400 |
Why?
|
Humans | 131 | 2025 | 765956 | 0.400 |
Why?
|
Nervous System Diseases | 4 | 2019 | 1660 | 0.400 |
Why?
|
Hematoma, Subdural | 1 | 2013 | 128 | 0.390 |
Why?
|
Predictive Value of Tests | 18 | 2025 | 15398 | 0.390 |
Why?
|
Perfusion Imaging | 2 | 2024 | 193 | 0.380 |
Why?
|
Brain | 13 | 2024 | 27178 | 0.370 |
Why?
|
Craniocerebral Trauma | 2 | 2010 | 494 | 0.370 |
Why?
|
Image Enhancement | 2 | 2017 | 2858 | 0.370 |
Why?
|
Retrospective Studies | 44 | 2024 | 81515 | 0.360 |
Why?
|
Endarterectomy, Carotid | 3 | 2024 | 557 | 0.360 |
Why?
|
Posthumous Conception | 1 | 2010 | 11 | 0.360 |
Why?
|
Diffusion Magnetic Resonance Imaging | 4 | 2023 | 2803 | 0.350 |
Why?
|
Male | 79 | 2024 | 363691 | 0.340 |
Why?
|
Third-Party Consent | 1 | 2010 | 66 | 0.340 |
Why?
|
Female | 76 | 2024 | 396101 | 0.340 |
Why?
|
Central Nervous System Neoplasms | 3 | 2024 | 916 | 0.330 |
Why?
|
Cerebral Veins | 1 | 2011 | 157 | 0.330 |
Why?
|
Hypoxia, Brain | 1 | 2010 | 139 | 0.330 |
Why?
|
Wounds, Nonpenetrating | 3 | 2010 | 807 | 0.330 |
Why?
|
Image Processing, Computer-Assisted | 9 | 2017 | 8927 | 0.320 |
Why?
|
Respiratory Paralysis | 1 | 2009 | 32 | 0.320 |
Why?
|
Cerebral Infarction | 2 | 2006 | 970 | 0.320 |
Why?
|
Head Injuries, Closed | 1 | 2010 | 133 | 0.320 |
Why?
|
Oocyte Retrieval | 1 | 2010 | 163 | 0.320 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2010 | 109 | 0.310 |
Why?
|
Phlebography | 1 | 2010 | 328 | 0.310 |
Why?
|
Mediterranean Sea | 3 | 2018 | 13 | 0.310 |
Why?
|
Stents | 3 | 2024 | 3213 | 0.310 |
Why?
|
Skull Fractures | 1 | 2010 | 202 | 0.310 |
Why?
|
Radiographic Image Enhancement | 3 | 2014 | 872 | 0.300 |
Why?
|
Trauma Severity Indices | 1 | 2009 | 479 | 0.290 |
Why?
|
Algorithms | 7 | 2023 | 14071 | 0.290 |
Why?
|
Observer Variation | 8 | 2017 | 2615 | 0.280 |
Why?
|
Brain Diseases | 2 | 2014 | 1546 | 0.280 |
Why?
|
Acute Disease | 7 | 2024 | 7232 | 0.270 |
Why?
|
Middle Cerebral Artery | 3 | 2016 | 268 | 0.270 |
Why?
|
Collateral Circulation | 2 | 2024 | 292 | 0.270 |
Why?
|
Imaging, Three-Dimensional | 3 | 2020 | 4034 | 0.270 |
Why?
|
Vascular Diseases | 2 | 2019 | 1159 | 0.260 |
Why?
|
Fibrinolytic Agents | 4 | 2024 | 2080 | 0.250 |
Why?
|
ROC Curve | 8 | 2022 | 3620 | 0.250 |
Why?
|
Ultrasonography | 2 | 2019 | 5993 | 0.240 |
Why?
|
Tracheostomy | 1 | 2009 | 429 | 0.240 |
Why?
|
Diagnosis, Differential | 10 | 2024 | 12976 | 0.240 |
Why?
|
Cerebral Arterial Diseases | 2 | 2023 | 82 | 0.230 |
Why?
|
Risk Factors | 22 | 2024 | 74836 | 0.230 |
Why?
|
Reproducibility of Results | 14 | 2023 | 20125 | 0.230 |
Why?
|
Adult | 37 | 2024 | 223038 | 0.220 |
Why?
|
Nicardipine | 2 | 2021 | 59 | 0.210 |
Why?
|
Brain Ischemia | 4 | 2017 | 3000 | 0.210 |
Why?
|
Pneumocephalus | 1 | 2023 | 46 | 0.200 |
Why?
|
Models, Theoretical | 1 | 2014 | 3564 | 0.200 |
Why?
|
Arterial Occlusive Diseases | 3 | 2016 | 729 | 0.200 |
Why?
|
Spinal Cord Injuries | 1 | 2009 | 928 | 0.190 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2023 | 283 | 0.190 |
Why?
|
Arteries | 2 | 2023 | 1118 | 0.180 |
Why?
|
Adolescent | 16 | 2019 | 88832 | 0.180 |
Why?
|
Cerebrovascular Circulation | 3 | 2024 | 2673 | 0.180 |
Why?
|
Young Adult | 16 | 2024 | 59886 | 0.180 |
Why?
|
Thrombolytic Therapy | 3 | 2024 | 2059 | 0.170 |
Why?
|
Vision Disorders | 2 | 2021 | 1087 | 0.170 |
Why?
|
Prognosis | 14 | 2018 | 29921 | 0.170 |
Why?
|
Ultrasonography, Doppler | 1 | 2002 | 460 | 0.170 |
Why?
|
Hypertension | 1 | 2019 | 8626 | 0.160 |
Why?
|
Echo-Planar Imaging | 2 | 2023 | 649 | 0.160 |
Why?
|
Severity of Illness Index | 10 | 2016 | 15880 | 0.160 |
Why?
|
Basilar Artery | 2 | 2015 | 206 | 0.160 |
Why?
|
Spain | 2 | 2018 | 483 | 0.160 |
Why?
|
Disease Progression | 10 | 2020 | 13631 | 0.160 |
Why?
|
Marine Biology | 1 | 2018 | 17 | 0.150 |
Why?
|
Glasgow Coma Scale | 4 | 2017 | 575 | 0.150 |
Why?
|
Leukoaraiosis | 1 | 2020 | 114 | 0.150 |
Why?
|
Constriction, Pathologic | 1 | 2022 | 1105 | 0.150 |
Why?
|
Plaque, Atherosclerotic | 3 | 2019 | 1530 | 0.150 |
Why?
|
Geologic Sediments | 2 | 2017 | 81 | 0.150 |
Why?
|
Glyburide | 1 | 2018 | 117 | 0.150 |
Why?
|
Bivalvia | 1 | 2017 | 54 | 0.150 |
Why?
|
Respiration, Artificial | 1 | 2009 | 2709 | 0.150 |
Why?
|
Perfusion | 2 | 2022 | 1407 | 0.150 |
Why?
|
Syndrome | 1 | 2024 | 3271 | 0.150 |
Why?
|
Emergency Medical Services | 1 | 2009 | 1938 | 0.140 |
Why?
|
Multivariate Analysis | 9 | 2020 | 12057 | 0.140 |
Why?
|
Herpesvirus 3, Human | 1 | 2018 | 159 | 0.140 |
Why?
|
Ultrasonography, Doppler, Color | 2 | 2015 | 235 | 0.140 |
Why?
|
Databases as Topic | 1 | 2018 | 471 | 0.130 |
Why?
|
Hemorrhage | 1 | 2009 | 3461 | 0.130 |
Why?
|
Early Termination of Clinical Trials | 1 | 2016 | 70 | 0.130 |
Why?
|
Incidence | 6 | 2017 | 21480 | 0.130 |
Why?
|
Gerstmann Syndrome | 1 | 2016 | 4 | 0.130 |
Why?
|
Plasminogen Activators | 1 | 2016 | 200 | 0.130 |
Why?
|
Child | 11 | 2019 | 80563 | 0.130 |
Why?
|
Apolipoproteins E | 2 | 2012 | 1458 | 0.130 |
Why?
|
Time Factors | 9 | 2024 | 40065 | 0.130 |
Why?
|
Metals, Heavy | 1 | 2017 | 151 | 0.130 |
Why?
|
Cohort Studies | 13 | 2018 | 41647 | 0.130 |
Why?
|
Circle of Willis | 1 | 2015 | 76 | 0.120 |
Why?
|
Herpes Zoster | 1 | 2018 | 252 | 0.120 |
Why?
|
Anterior Cerebral Artery | 1 | 2015 | 49 | 0.120 |
Why?
|
Blood Pressure | 4 | 2021 | 8532 | 0.120 |
Why?
|
Causality | 2 | 2013 | 1248 | 0.120 |
Why?
|
Warfarin | 3 | 2014 | 1494 | 0.120 |
Why?
|
Lymphoma | 1 | 2024 | 1897 | 0.120 |
Why?
|
Pons | 1 | 2016 | 238 | 0.120 |
Why?
|
Blood-Brain Barrier | 1 | 2002 | 1037 | 0.120 |
Why?
|
Survival Rate | 6 | 2013 | 12795 | 0.120 |
Why?
|
Hypocalcemia | 1 | 2016 | 205 | 0.120 |
Why?
|
Water Movements | 1 | 2014 | 17 | 0.120 |
Why?
|
Single-Blind Method | 2 | 2015 | 1588 | 0.120 |
Why?
|
Teleradiology | 1 | 2014 | 52 | 0.110 |
Why?
|
Brain Edema | 1 | 2018 | 602 | 0.110 |
Why?
|
Apolipoprotein E2 | 2 | 2012 | 133 | 0.110 |
Why?
|
Blood Cells | 1 | 2016 | 307 | 0.110 |
Why?
|
Avitaminosis | 1 | 2014 | 35 | 0.110 |
Why?
|
Central Nervous System Infections | 1 | 2014 | 61 | 0.110 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2021 | 1376 | 0.110 |
Why?
|
Research Design | 1 | 2009 | 6208 | 0.110 |
Why?
|
Incidental Findings | 1 | 2018 | 697 | 0.110 |
Why?
|
Climate | 1 | 2014 | 147 | 0.110 |
Why?
|
Water Pollutants, Chemical | 1 | 2017 | 358 | 0.110 |
Why?
|
Radiography | 4 | 2014 | 6919 | 0.110 |
Why?
|
Prospective Studies | 11 | 2024 | 54806 | 0.110 |
Why?
|
Ecosystem | 1 | 2017 | 488 | 0.110 |
Why?
|
Brain Concussion | 1 | 2025 | 1432 | 0.110 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2016 | 360 | 0.110 |
Why?
|
Moyamoya Disease | 1 | 2016 | 273 | 0.100 |
Why?
|
Logistic Models | 7 | 2020 | 13266 | 0.100 |
Why?
|
Craniopharyngioma | 1 | 2015 | 276 | 0.100 |
Why?
|
Area Under Curve | 3 | 2014 | 1638 | 0.100 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2014 | 462 | 0.100 |
Why?
|
Conservation of Natural Resources | 1 | 2014 | 209 | 0.100 |
Why?
|
Neuroprotective Agents | 1 | 2018 | 959 | 0.100 |
Why?
|
Treatment Outcome | 14 | 2024 | 65189 | 0.100 |
Why?
|
Chi-Square Distribution | 3 | 2017 | 3432 | 0.100 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2021 | 1076 | 0.090 |
Why?
|
Child, Preschool | 7 | 2019 | 42500 | 0.090 |
Why?
|
Radiology, Interventional | 1 | 2016 | 485 | 0.090 |
Why?
|
Penis | 1 | 2012 | 209 | 0.090 |
Why?
|
False Positive Reactions | 1 | 2014 | 955 | 0.090 |
Why?
|
Brazil | 1 | 2015 | 1248 | 0.090 |
Why?
|
Anticoagulants | 4 | 2022 | 4862 | 0.090 |
Why?
|
Public Health | 1 | 2024 | 2680 | 0.090 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2014 | 636 | 0.090 |
Why?
|
Risk Assessment | 7 | 2024 | 24283 | 0.090 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2014 | 664 | 0.090 |
Why?
|
Odds Ratio | 4 | 2018 | 9649 | 0.090 |
Why?
|
Postoperative Hemorrhage | 1 | 2014 | 413 | 0.090 |
Why?
|
Patient Admission | 2 | 2012 | 1365 | 0.090 |
Why?
|
Ethics Committees, Clinical | 1 | 2010 | 56 | 0.090 |
Why?
|
Blood Loss, Surgical | 1 | 2014 | 629 | 0.090 |
Why?
|
Biopsy | 2 | 2019 | 6763 | 0.090 |
Why?
|
Follow-Up Studies | 9 | 2016 | 39194 | 0.080 |
Why?
|
Erectile Dysfunction | 1 | 2013 | 437 | 0.080 |
Why?
|
Infant | 6 | 2019 | 36385 | 0.080 |
Why?
|
Washington | 1 | 2010 | 314 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2020 | 3358 | 0.080 |
Why?
|
Catheters, Indwelling | 1 | 2012 | 438 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3596 | 0.080 |
Why?
|
Brucella melitensis | 1 | 2008 | 7 | 0.080 |
Why?
|
Boston | 2 | 2013 | 9338 | 0.080 |
Why?
|
Delayed Diagnosis | 1 | 2012 | 452 | 0.080 |
Why?
|
Jugular Veins | 1 | 2010 | 211 | 0.080 |
Why?
|
Comparative Effectiveness Research | 1 | 2014 | 714 | 0.080 |
Why?
|
Brucellosis | 1 | 2008 | 21 | 0.080 |
Why?
|
Carotid Artery, Common | 1 | 2009 | 172 | 0.080 |
Why?
|
Eye Diseases | 2 | 2021 | 659 | 0.080 |
Why?
|
Educational Measurement | 1 | 2016 | 1260 | 0.080 |
Why?
|
Databases, Factual | 1 | 2024 | 8067 | 0.080 |
Why?
|
Hospitals, General | 1 | 2013 | 802 | 0.080 |
Why?
|
Behcet Syndrome | 1 | 2009 | 86 | 0.080 |
Why?
|
Environment | 1 | 2014 | 1114 | 0.070 |
Why?
|
Infusions, Intra-Arterial | 1 | 2008 | 218 | 0.070 |
Why?
|
Intracranial Hypertension | 1 | 2010 | 190 | 0.070 |
Why?
|
Anemia, Sickle Cell | 1 | 2016 | 1067 | 0.070 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2008 | 113 | 0.070 |
Why?
|
Epidural Abscess | 1 | 2008 | 96 | 0.070 |
Why?
|
Artifacts | 2 | 2023 | 1893 | 0.070 |
Why?
|
Polychondritis, Relapsing | 1 | 2007 | 27 | 0.070 |
Why?
|
Tracheal Stenosis | 1 | 2009 | 227 | 0.070 |
Why?
|
Pituitary Neoplasms | 1 | 2015 | 1321 | 0.070 |
Why?
|
Mutation | 3 | 2024 | 30196 | 0.070 |
Why?
|
Survival Analysis | 2 | 2016 | 10070 | 0.070 |
Why?
|
Vasculitis | 2 | 2009 | 527 | 0.070 |
Why?
|
Withholding Treatment | 1 | 2010 | 621 | 0.060 |
Why?
|
Pneumonia, Ventilator-Associated | 1 | 2009 | 279 | 0.060 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2015 | 2054 | 0.060 |
Why?
|
Wounds and Injuries | 2 | 2012 | 2511 | 0.060 |
Why?
|
Ear Diseases | 1 | 2007 | 179 | 0.060 |
Why?
|
Vertebral Artery | 1 | 2006 | 184 | 0.060 |
Why?
|
Cryopreservation | 1 | 2010 | 728 | 0.060 |
Why?
|
Comorbidity | 3 | 2017 | 10563 | 0.060 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2014 | 1211 | 0.060 |
Why?
|
Infant, Premature | 1 | 2014 | 2122 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2822 | 0.060 |
Why?
|
Gadolinium | 1 | 2009 | 965 | 0.050 |
Why?
|
Mammography | 1 | 2014 | 2423 | 0.050 |
Why?
|
Coronary Stenosis | 1 | 2009 | 800 | 0.050 |
Why?
|
Calcium | 1 | 2016 | 5767 | 0.050 |
Why?
|
Functional Laterality | 1 | 2010 | 2243 | 0.050 |
Why?
|
Trachea | 1 | 2009 | 1085 | 0.050 |
Why?
|
Cerebrospinal Fluid | 2 | 2021 | 539 | 0.050 |
Why?
|
Emergency Service, Hospital | 2 | 2014 | 7875 | 0.050 |
Why?
|
Optic Nerve | 2 | 2021 | 567 | 0.050 |
Why?
|
Penile Erection | 2 | 2013 | 100 | 0.050 |
Why?
|
Malaria, Falciparum | 1 | 2011 | 1075 | 0.050 |
Why?
|
Testosterone | 1 | 2013 | 2494 | 0.050 |
Why?
|
Regression Analysis | 1 | 2012 | 6321 | 0.050 |
Why?
|
Curriculum | 1 | 2016 | 3782 | 0.050 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2741 | 0.050 |
Why?
|
Hypoventilation | 1 | 2001 | 43 | 0.050 |
Why?
|
Pulmonary Artery | 1 | 2010 | 1935 | 0.050 |
Why?
|
Intubation, Intratracheal | 1 | 2009 | 1303 | 0.050 |
Why?
|
Viscera | 1 | 2002 | 137 | 0.050 |
Why?
|
Plasmodium falciparum | 1 | 2011 | 1738 | 0.050 |
Why?
|
Myosin Heavy Chains | 1 | 2023 | 403 | 0.050 |
Why?
|
Environmental Monitoring | 2 | 2017 | 1470 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3685 | 0.050 |
Why?
|
Eye Pain | 1 | 2021 | 46 | 0.040 |
Why?
|
Alleles | 1 | 2012 | 6897 | 0.040 |
Why?
|
Prevalence | 4 | 2013 | 15839 | 0.040 |
Why?
|
Occupational Diseases | 1 | 2008 | 1456 | 0.040 |
Why?
|
Heart Arrest | 1 | 2010 | 1516 | 0.040 |
Why?
|
Calcinosis | 1 | 2009 | 1479 | 0.040 |
Why?
|
Skin | 1 | 2014 | 4489 | 0.040 |
Why?
|
Diffusion | 1 | 2002 | 808 | 0.040 |
Why?
|
Blood Cell Count | 1 | 2021 | 405 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2014 | 12769 | 0.040 |
Why?
|
DNA, Neoplasm | 1 | 2024 | 1742 | 0.040 |
Why?
|
Reference Standards | 2 | 2015 | 1013 | 0.040 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2002 | 499 | 0.040 |
Why?
|
Abdominal Injuries | 1 | 2002 | 363 | 0.040 |
Why?
|
Bioprosthesis | 1 | 2002 | 589 | 0.040 |
Why?
|
Whole Body Imaging | 1 | 2010 | 281 | 0.040 |
Why?
|
Uncertainty | 1 | 2023 | 761 | 0.040 |
Why?
|
Veins | 1 | 2002 | 764 | 0.040 |
Why?
|
Tuberculosis | 2 | 2008 | 2012 | 0.040 |
Why?
|
Cardiovascular Diseases | 2 | 2013 | 15651 | 0.030 |
Why?
|
Ecology | 1 | 2017 | 105 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2015 | 9373 | 0.030 |
Why?
|
Trauma Centers | 1 | 2002 | 952 | 0.030 |
Why?
|
Rupture, Spontaneous | 1 | 2017 | 359 | 0.030 |
Why?
|
Acute Kidney Injury | 1 | 2009 | 1946 | 0.030 |
Why?
|
Pulmonary Embolism | 1 | 2010 | 2598 | 0.030 |
Why?
|
Optic Disk | 1 | 2021 | 421 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2022 | 2770 | 0.030 |
Why?
|
Endovascular Procedures | 2 | 2024 | 2222 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11888 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2012 | 8041 | 0.030 |
Why?
|
Intensive Care Units | 1 | 2009 | 3800 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2018 | 591 | 0.030 |
Why?
|
Animals | 3 | 2018 | 168759 | 0.030 |
Why?
|
Length of Stay | 1 | 2009 | 6485 | 0.030 |
Why?
|
Central Nervous System | 1 | 2023 | 1341 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2016 | 9071 | 0.030 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 1997 | 292 | 0.030 |
Why?
|
Adenine | 1 | 2021 | 994 | 0.030 |
Why?
|
Cerebral Cortex | 1 | 2011 | 5767 | 0.030 |
Why?
|
Hematologic Tests | 1 | 2016 | 239 | 0.030 |
Why?
|
Speech Disorders | 1 | 2016 | 178 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2014 | 26349 | 0.030 |
Why?
|
Iodine | 1 | 2017 | 288 | 0.030 |
Why?
|
Heart Valve Diseases | 1 | 2002 | 1030 | 0.030 |
Why?
|
Calibration | 1 | 2017 | 814 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11868 | 0.030 |
Why?
|
Oximes | 1 | 2015 | 305 | 0.030 |
Why?
|
Ascorbic Acid Deficiency | 1 | 2014 | 26 | 0.030 |
Why?
|
Fractals | 1 | 2014 | 124 | 0.030 |
Why?
|
Valine | 1 | 2015 | 410 | 0.030 |
Why?
|
Heart Valve Prosthesis | 1 | 2002 | 1466 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22340 | 0.030 |
Why?
|
Patient Simulation | 1 | 2016 | 301 | 0.030 |
Why?
|
Vitamin A Deficiency | 1 | 2014 | 88 | 0.030 |
Why?
|
Genotype | 3 | 2012 | 13024 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2015 | 384 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2018 | 906 | 0.030 |
Why?
|
Aortic Valve | 1 | 2002 | 1968 | 0.030 |
Why?
|
Problem-Based Learning | 1 | 2016 | 360 | 0.020 |
Why?
|
Piperidines | 1 | 2021 | 1664 | 0.020 |
Why?
|
Pain | 2 | 2021 | 5077 | 0.020 |
Why?
|
Hemodynamics | 1 | 2002 | 4183 | 0.020 |
Why?
|
Coitus | 1 | 2012 | 133 | 0.020 |
Why?
|
Point-of-Care Systems | 2 | 2011 | 1217 | 0.020 |
Why?
|
Aorta, Abdominal | 1 | 2014 | 596 | 0.020 |
Why?
|
Craniotomy | 1 | 2015 | 730 | 0.020 |
Why?
|
HIV Infections | 1 | 2017 | 17533 | 0.020 |
Why?
|
Data Interpretation, Statistical | 2 | 2012 | 2686 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2015 | 1009 | 0.020 |
Why?
|
Recurrence | 1 | 2023 | 8501 | 0.020 |
Why?
|
Peripheral Vascular Diseases | 1 | 2013 | 516 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 18071 | 0.020 |
Why?
|
Pyridones | 1 | 2015 | 816 | 0.020 |
Why?
|
Software | 2 | 2017 | 4462 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2015 | 1180 | 0.020 |
Why?
|
Demography | 1 | 2014 | 1641 | 0.020 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2011 | 353 | 0.020 |
Why?
|
Imidazoles | 1 | 2015 | 1162 | 0.020 |
Why?
|
Waist Circumference | 1 | 2013 | 933 | 0.020 |
Why?
|
Thromboembolism | 1 | 2016 | 1003 | 0.020 |
Why?
|
Brain Stem | 1 | 2014 | 853 | 0.020 |
Why?
|
Exanthema | 1 | 2014 | 502 | 0.020 |
Why?
|
Reperfusion | 1 | 2010 | 267 | 0.020 |
Why?
|
Genital Diseases, Male | 1 | 2009 | 84 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2017 | 2475 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 2 | 2009 | 1808 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2904 | 0.020 |
Why?
|
International Normalized Ratio | 1 | 2010 | 381 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2020 | 22222 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2014 | 1499 | 0.020 |
Why?
|
Apolipoprotein E4 | 1 | 2012 | 707 | 0.020 |
Why?
|
Erythema | 1 | 2009 | 262 | 0.020 |
Why?
|
Otitis Externa | 1 | 2007 | 17 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4850 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 1 | 2013 | 1167 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2014 | 21056 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6832 | 0.020 |
Why?
|
Tuberculosis, Central Nervous System | 1 | 2006 | 16 | 0.020 |
Why?
|
Neck Pain | 1 | 2008 | 190 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6499 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2013 | 1811 | 0.020 |
Why?
|
Bacteria | 1 | 2017 | 2209 | 0.020 |
Why?
|
Demyelinating Diseases | 1 | 2009 | 355 | 0.020 |
Why?
|
Nose Diseases | 1 | 2007 | 79 | 0.020 |
Why?
|
Ear | 1 | 2007 | 172 | 0.020 |
Why?
|
Tuberculosis, Meningeal | 1 | 2006 | 46 | 0.020 |
Why?
|
Uganda | 1 | 2011 | 1353 | 0.020 |
Why?
|
Triglycerides | 1 | 2013 | 2441 | 0.020 |
Why?
|
Vascular Surgical Procedures | 1 | 2014 | 1485 | 0.020 |
Why?
|
United States | 3 | 2024 | 72898 | 0.020 |
Why?
|
Heart Block | 1 | 2007 | 391 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2007 | 433 | 0.020 |
Why?
|
Spleen | 1 | 2011 | 2296 | 0.010 |
Why?
|
Hospitals, Urban | 1 | 2006 | 493 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2009 | 1831 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2845 | 0.010 |
Why?
|
Vitamin D Deficiency | 1 | 2014 | 1348 | 0.010 |
Why?
|
Creatinine | 1 | 2009 | 1915 | 0.010 |
Why?
|
Edema | 1 | 2007 | 760 | 0.010 |
Why?
|
Night Care | 1 | 2002 | 28 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12509 | 0.010 |
Why?
|
Prednisone | 1 | 2007 | 1565 | 0.010 |
Why?
|
Cervical Vertebrae | 1 | 2008 | 974 | 0.010 |
Why?
|
Computer Simulation | 1 | 2016 | 6255 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4427 | 0.010 |
Why?
|
Celiac Artery | 1 | 2002 | 65 | 0.010 |
Why?
|
After-Hours Care | 1 | 2002 | 103 | 0.010 |
Why?
|
Dominance, Cerebral | 1 | 2003 | 616 | 0.010 |
Why?
|
Mesenteric Veins | 1 | 2002 | 86 | 0.010 |
Why?
|
Mesenteric Arteries | 1 | 2002 | 177 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8297 | 0.010 |
Why?
|
Fever | 1 | 2008 | 1603 | 0.010 |
Why?
|
Communicable Diseases | 1 | 2009 | 874 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11022 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2013 | 4040 | 0.010 |
Why?
|
Sex Factors | 1 | 2014 | 10602 | 0.010 |
Why?
|
Wounds, Penetrating | 1 | 2002 | 317 | 0.010 |
Why?
|
Hypercapnia | 1 | 2001 | 259 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 2003 | 1478 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8871 | 0.010 |
Why?
|
Vascular Patency | 1 | 2003 | 912 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 5696 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2010 | 2098 | 0.010 |
Why?
|
Injury Severity Score | 1 | 2002 | 1050 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 18973 | 0.010 |
Why?
|
California | 1 | 2002 | 1436 | 0.010 |
Why?
|
DNA | 1 | 2012 | 7202 | 0.010 |
Why?
|
Occupational Exposure | 1 | 2008 | 1805 | 0.010 |
Why?
|
Sinusitis | 1 | 2007 | 995 | 0.010 |
Why?
|
Blood Flow Velocity | 1 | 2001 | 1381 | 0.010 |
Why?
|
Heart | 1 | 2011 | 4414 | 0.010 |
Why?
|
Cuba | 1 | 1997 | 48 | 0.010 |
Why?
|
Vasodilation | 1 | 2001 | 970 | 0.010 |
Why?
|
Pilot Projects | 1 | 2011 | 8733 | 0.010 |
Why?
|
Smoking | 1 | 2014 | 9081 | 0.010 |
Why?
|
HIV-1 | 1 | 2014 | 6944 | 0.010 |
Why?
|
Nutrition Disorders | 1 | 1997 | 203 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2009 | 4209 | 0.010 |
Why?
|
Genetic Variation | 1 | 2011 | 6610 | 0.010 |
Why?
|
Obesity | 2 | 2013 | 13075 | 0.010 |
Why?
|
Reference Values | 1 | 2001 | 4908 | 0.010 |
Why?
|
Anthropometry | 1 | 1997 | 1338 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 26313 | 0.010 |
Why?
|
Nutrition Surveys | 1 | 1997 | 1741 | 0.010 |
Why?
|
Nutritional Status | 1 | 1997 | 1620 | 0.000 |
Why?
|
Socioeconomic Factors | 1 | 1997 | 7836 | 0.000 |
Why?
|